PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Octagon Research Solutions, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kirk Gallion of Octagon Research Solutions, Inc. Named to Prestigious 40 Under 40 - Octagon’s President Kirk Gallion, has been named as one of the regions 40 individuals, under the age of 40, being honored with this special acknowledgement
Kirk Gallion of Octagon Research Solutions, Inc. Named to Prestigious 40 Under 40

 

NewswireToday - /newswire/ - Wayne, PA, United States, 2007/03/20 - Octagon’s President Kirk Gallion, has been named as one of the regions 40 individuals, under the age of 40, being honored with this special acknowledgement.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Philadelphia Business Journal has recognized 40 individuals under the age of 40 who reflect the ideal professional in today’s society

CEO & Chairman Jim Walker of Octagon Research Solutions, Inc., a pioneer and leader in the electronic transformation of clinical R&D in the life sciences industry, announced today that Octagon’s President Kirk Gallion, has been named as one of the regions 40 individuals, under the age of 40, being honored with this special acknowledgement. The 40 under 40 Awards Program recognizes and profiles the Philadelphia region’s most accomplished young professionals who are proven performers in both their industry and their community.

The 40 recipients are up and coming young leaders who have shaped our community in ways that have made Greater Philadelphia a better place to do business and live. According to Editor Bernard Dagenais, “This program enables the Philadelphia Business Journal, and our high-powered readers, to learn about some of the rising business leaders in the region. These are people who distinguish themselves through their talent and their actions, on behalf of companies and causes that help to define the business community.” While working to improve the life sciences industry, Kirk Gallion has shown business success, measurable achievements, and dedication to his community.

“Kirk and I founded Octagon in 1999 on the conviction that we could create a company that would transform the way industry approaches clinical R&D”, stated Jim Walker. “Kirk is an innovative leader who is committed to identifying and cultivating internal talent, and combined with his love of technology, has created an entrepreneurial environment where innovation is not only encouraged, but expected. Kirk is truly deserving of this award, and it has been my privilege to work with him these past eight years.”

Kirk Gallion’s profile will be printed in a special editorial section of the Philadelphia Business Journal on May 4 and he will also be recognized at an awards banquet on Wednesday, May 2, 2007 at the Sheraton Society Hill. One of the 40 winners will be chosen for the Outstanding Young Entrepreneur Award, a new addition this year. The program is sponsored by Bank of America, Comcast Spectacor, Temple University’s Fox School of Business and Southwest Airlines.

The Philadelphia Business Journal is the region’s local business news source providing a weekly newspaper, daily web updates, and a series of events that bring people together. It is a part of American City Business Journals with 41 publications across the nation.

About Octagon’s Kirk Gallion

Kirk Gallion, co-founder and presidentof Octagon Research Solutions, Inc., is committed to the development of new and enhanced technologies that automate, accelerate and advance the drug development process. He has worked in the industry for over 10 years. Prior to Octagon, Mr. Gallion worked as a technology consultant for Andersen Consulting. While at Andersen, he was responsible for the installation and customization of an imaging system for a large pharmaceutical company (AstraZeneca), developing a system of corporate intranet websites, and developing automated tools to facilitate electronic publishing.

Prior to joining Andersen, Mr. Gallion served as a captain in the United States Army. During his tenure, he was awarded the Army Commendation Medal, and two Army Achievement medals in addition to being rated the best of 68 junior officers in the command.

Mr. Gallion holds a Bachelor of Science degree in Physics from Frostburg State University where he was a member of numerous honor societies in math and physics.

About Octagon Research Solutions, Inc.

Octagonis a pioneer and leading process-centric solutions provider that offers a suite of regulatory, clinical, process, and IT solutions to the life sciences industry. Octagon synchronizes processes and increases automation to reduce island-to-island inefficiencies within the clinical research and development process. We leverage the power of electronic submissions through deep domain knowledge, cross-functional electronic submission expertise, a holistic process approach, and integrated solutions. Octagon is headquartered in Wayne, PA, with European headquarters in Amersham, UK.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Octagon Research Solutions, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kirk Gallion of Octagon Research Solutions, Inc. Named to Prestigious 40 Under 40

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Graham 
610 535 6500 x5655 jgraham[.]octagonresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Octagon Research Solutions, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Octagon Research Solutions, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  MagLar, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)